ORA is experiencing staffing issues and we ask your patience while we fill the positions. To ensure that we
are able to provide thorough support, please route your proposals and documents as soon as possible. Thank you.
The Office of Technology Development will offer the Innovation to Impact Series Session 4 – “Post Graduate
Venture Fellowship Program.” Hear from a current Venture Fellow commercializing technology from his graduate
research; Explore the skills needed for a career in industry or entrepreneurship and Learn about program details,
including selection, curriculum and goals. Vince Sandifer, current Venture Fellow, will be presenting. This session
will occur on November 20th from Noon- 1:00 pm in Biomedical Research Center Building, Room 103. Lunch will
be provided. Please RSVP to email@example.com by November 14th. Space is limited to the first 15 attendees.
NIH Requests Public Comment on a Draft Policy for Data Management and Sharing and
Supplemental Draft Guidance
Today, NIH released a Draft NIH Policy for Data Management and Sharing and supplemental draft guidance for
public comment. The purpose of this draft policy and supplemental draft guidance is to promote effective and
efficient data management and sharing that furthers NIH’s commitment to making the results and accomplishments
of the research it funds and conducts available to the public. Complete information about the draft Policy and draft
supplemental guidance can be found on the NIH OSP website.
Stakeholder feedback is essential to ensure that any future policy maximizes responsible data sharing, minimizes
burden on researchers, and protects the privacy of research participants. Stakeholders are invited to comment
on any aspect of the draft policy, the supplemental draft guidance, or any other considerations relevant to NIH’s
data management and sharing policy efforts that NIH should consider.
To facilitate commenting, NIH has established a web portal that can be accessed here:
https://osp.od.nih.gov/draft-data-sharing-and-management/. To ensure consideration, comments must be
received no later than January 10, 2020. For additional details about NIH’s thinking on this issue, please
see Dr. Carrie Wolinetz’ latest Under the Poliscope blog:
“NIH’s DRAFT Data Management and Sharing Policy: We Need to Hear From You!”
NIH will also be hosting a webinar on the draft policy in the near future. Please stay tuned for details.
Questions may be sent to SciencePolicy@mail.nih.gov.
New “All About Grants” Podcast on Managing Conflicts of Interest in Peer Review
In this next installment of the NIH’s All About Grants podcast series, we talk about how NIH manages conflicts
of interest to ensure that we maintain integrity throughout the peer review process. Sally Amero, Ph.D., NIH’s
Review Policy Officer, joins us and explains why it is important to manage these conflicts, what is and is not a
potential conflict, how to disclose conflicts, and who is involved throughout the peer review process.
NIH: All pending support at the time of application submission and prior to award must be reported using
"Just-in-Time Procedures" by providing all information indicated above. Applicants are responsible for promptly
notifying NIH of any substantive changes to previously submitted Just-in-Time information up to the time of award,
including "Other Support" changes that must be assessed for budgetary or scientific overlap. Further, if other
support, as described as above, is obtained after the initial NIH award period, from any source either through the
institution or directly to senior/key personnel, the details must be disclosed in the annual research performance
progress report (RPPR). Post-award, recipients must address any substantive changes by submitting a prior
approval request to NIH in accordance with the NIHGPS section on "Administrative Requirements-Changes in
Project and Budget-NIH Standard Terms of Award."
See NOT-OD-19-114 https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-114.html
GCA Newsletter for November 2019 is attached.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/GCA News November 2019.pdf?ver=2019-11-04-083855-253
PRESBYTERIAN HEALTH FOUNDATION GRANTS – REQUEST FOR APPLICATIONS – CYCLE III
BRIDGE GRANT PROGRAM– DUE DATE NOVEMBER 15, 2019
The primary objective of the PHF Bridge Grant program is to provide funding to enhance OUHSC faculty
competitiveness for extramural funding. OUHSC Principal Investigators who have submitted an extramural
application that was scored but not funded within the past 18 months and is requesting over $750,000 in total
direct costs and over $200,000 in total facilities and administration (F&A) costs and received a review that
ranks applications and provides critiques are eligible. This program can provide funding for up to $75,000 for
one year. Guidelines and Application Form is attached or can be found at:
https://research.ouhsc.edu/Portals/1329/Assets/Documents/PHF-Bridge Grant Guidelines - 2019-October 23 2019-Revised.docx?ver=2019-10-28-083210-947
END2Cancer: Emerging Nanotechnology and Drug Delivery
Applications for Cancer Conference
November 20 - 22, 2019
Samis Education Center at the OU Children's Hospital, Oklahoma City
Click here to register: https://ouhsc.qualtrics.com/jfe/form/SV_cN57MHTc7Lt5Rel
Pat Tillman Foundation Informational Workshop – November 20, 2019 from 12:00PM to 1:00PM at
the David L. Boren Student Union, Room 260. https://pattillmanfoundation.org/the-foundation/
Office of Technology Development presents a fifth opportunity to engage with industry (click here
http://www.ou.edu/otd/ICO for more information, or email firstname.lastname@example.org or email@example.com
for specific submission details):
- UCB is looking to engage with academia in the gene therapy space for developing new treatments
for neurological disorders. Focus areas* include:
- Viral delivery approaches using AAV or non-viral approaches (e.g., LNPs or EVs)
- Accessory approaches facilitating better delivery/enhanced expression of genes
- Approaches targeting gene therapy candidates and their allied pathways
- Out of scope: lentiviral or antisense oligonucleotide delivery approaches (unless transformed for use
*Basic/pre-clinical research stages are within scope; however, highest priority is research with existing
in vivo validation. Non-confidential, 1-3 page application due 11/29/2019.
This Workshop has been postponed: UPDATE! Don’t miss out! ORA/GCA/Purchasing Workshop
Ever wondered who we are and what we do?
Ever needed help with a grant submission?
Not quite sure how to support your faculty with their grants and contracts?
Are you struggling with a human subjects section of your proposal?
Are budget and compliance questions keeping you from your real job?
Finally the moment you’ve been waiting for….
We are pleased to announce a joint workshop, “The OUHSC World of Grants & Contracts” for faculty and
staff. This workshop will offer a one-day training on sponsored research topics. The sessions are the same
for both days, just different times. The information will be provided in a variety of formats ranging from talks
to breakout sessions with experts sitting at tables eager to answer all your questions.
Harold Hamm Diabetes Center (HHDC) Research Symposium
The 2019 HHDC Research Symposium will be held on Friday, November 15, 2019 at the Samis Education
Center in Children’s Hospital in Oklahoma City. The Symposium will consist of selected oral presentations,
a poster session, and Symposia talks by P. Darrell Neufer, PhD, Professor, East Carolina University,
Matthew Rodeheffer PhD, Associate Professor, Yale University and Scott Summers, PhD, Professor and
Chair, The University of Utah. For abstract submission guidelines and to RSVP for this free event, please
go to: https://hammdiabetescenter.org/Research/Symposium
Please contact Katie-Hoefling@ouhsc.edu with any questions for this event.
i2E Entrepreneurial Summit on Friday, November 15, 2019 at 9:00 am – 1:00 pm at the Reed
Conference Center, Midwest City 73110. See attached document for more complete information.
NIH Extension Policy for Eligibility Window for Pathway to Independence Awards (K99/R00)
FSMA Preventive Controls and Mutual Reliance Implementation Expansion Supplement to RFA-FD-18-001
Notice of Pre-Application Webinar for PA-18-817 "Administrative Supplements for Research on Dietary
Supplements" and PA-18-818 "Administrative Supplements for Validation Studies of Analytical Methods
for Dietary Supplement Constituents" (NOT-OD-20-014)
Request for Information (RFI): Input on Research Opportunities on the Anterior Segment of the Eye
Notice to Rescind NOT-AA-19-025 "Notice of Intent to Publish a Funding Opportunity Announcement for
Early Liver Transplantation Cohort Study (U10 - Clinical Trial Optional) " (NOT-AA-19-030)
Notice to Extend the Expiration Date for PAR-17-032 (NOT-AG-20-005)
Notice to Remove the Letter of Intent Due Date from PAS-19-391, PAS-19-392, and PAS-19-393
Notice to Extend the Expiration Date for PAR-17-033 (NOT-AG-20-007)
Clarification of Research Areas for NIAID RFA-AI-19-059: Accelerating Discovery of Efficacious
Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) (NOT-AI-20-006)
Notice to Extend the Response Date for NOT-AR-19-039 "Request for Information (RFI) on the Lessons
Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis and Lupus (AMP RA/SLE
Notice of Additional Research Objectives for PAS-19-105, Stimulating Hematology Investigation: New
Endeavors (SHINE) (R01 Clinical Trial Not Allowed) (NOT-DK-19-028)
Notice of Additional Receipt Date for PAR-18-925, Pragmatic Research in Healthcare Settings to Improve
Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required) (NOT-DK-20-006)
Notice of Additional Receipt Date for PAR-18-924, Planning Grants for Pragmatic Research in Healthcare
Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required) (NOT-DK-20-007)
Notice of Additional Receipt Date for PAR-17-178, Evaluating Natural Experiments in Healthcare to
Improve Diabetes Prevention and Treatment (R18) (NOT-DK-20-008)
Notice of Intent to Publish the Reissuance of PAR-18-644 and PAR-18-645 for Research Infrastructure
Development for Interdisciplinary Aging Studies (R33 and R21/R33) (NOT-AG-20-004)
Notice of Intent to Publish a Funding Opportunity Announcement for Implementing the HIV Service
Cascade for Justice-Involved Populations (NOT-DA-20-003)
Notice of Special Interest (NOSI) of NIDCR in Supporting Discovery, Characterization, and Mechanistic
Study of Genetic Variants Underlying Dental, Oral, and Craniofacial Diseases and Conditions (NOT-DE-19-016)
Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition,
Microbiome and Digestive Disease Applications (NOT-DK-20-001)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Communication and Decision Making for Individuals with Inherited Cancer Syndromes
(U01 Clinical Trial Optional) (RFA-CA-20-006) - Deadline January 21, 2020
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets
(R61/R33 Clinical Trial Not Allowed) (RFA-NS-20-007) – Deadline March 17, 2020
OTHER FEDERAL DEADLINES
National Science Foundation (NSF) EPSCoR Research Infrastructure Improvement Program:
Track 2 Solicitation – Required Letter of Intent Due December 20, 2019; Full Proposal Due January 24, 2020
American Brain Tumor Association – Basic Research Fellowships – Deadline for Required
Letter of Intent is December 4, 2019
American Brain Tumor Association – Discovery Grants – Deadline for Required Letter of Intent is
December 4, 2019
Oklahoma Center for Adult Stem Cell Research (OCASCR) – Grant Deadline January 28, 2010